2025 -  WEEK 22

What's New in RWE Research this Week

  1. Understanding the Experiences of Patients With Pancreatic Cancer: Quantitative Analysis of the Pancreatic Cancer Action Network Patient Registry. Rosenzweig A, Rathjens S, Abdilleh K, Ladnier D, Zelada-Arenas F, Doss S, Matrisian LM.J Particip Med. 2025 May 26;17:e65046. doi: 10.2196/65046.PMID: 40418805 Free article.

 

  1. Attrition rates and treatment outcomes in multiple myeloma: real-world data over a 40-year period. Rodríguez-Lobato LG, de Daniel A, Pereira A, Fernández de Larrea C, Tovar N, Cibeira MT, Moreno DF, Mateos JM, Llobet N, Carcelero E, Munárriz D, Bladé J, Rosiñol L.Blood Cancer J. 2025 May 26;15(1):103. doi: 10.1038/s41408-025-01311-y.PMID: 40419498 Free

 

  1. Real-world use, effectiveness, and safety of second-line lurbinectedin monotherapy in small cell lung cancer. Ganti AK, D'Agostino RB Jr, Allan V, Prince P, Estrin A, Gautam N, Boccuti A, Rengarajan B, Li W, Cao Y, Fan X, Poole EM.Future Oncol. 2025 May 26:1-11. doi: 10.1080/14796694.2025.2499441. Online ahead of print.PMID: 40420490

 

  1. Incidence and Characteristics of Infectious Complications in Multiple Myeloma Patients Treated With Bispecific Antibodies. Park T, Jang S, Koh Y, Shin DY, Yoon SS, Lee CM, Jo HJ, Choe PG, Park WB, Kim NJ, Kang CK, Byun JM.J Korean Med Sci. 2025 May 26;40(20):e86. doi: 10.3346/jkms.2025.40.e86.PMID: 40425193 Free PMC article.

 

  1. PFO Device Closure in Patients >60 Years of Age With Ischemic Stroke: Results From U.S. Medicare Beneficiaries. Satpathy R, Rodés-Cabau J, Thaler DE, Kent DM, Turner S, Potluri S, Kolli KK, Borgstrom NP, Prillinger JB, Saver JL.JACC Cardiovasc Interv. 2025 May 26;18(10):1303-1314. doi: 10.1016/j.jcin.2025.03.034.PMID: 40436496

 

  1. Reappraising Glucocorticoid Tapering in Rheumatoid Arthritis: Immunomodulatory Edge of Integrated Chinese and Western Medicine through Real-World Evidence. Zhan CG, Huang RY.Chin J Integr Med. 2025 May 27. doi: 10.1007/s11655-025-4223-0. Online ahead of print.PMID: 40419844 No abstract available.

 

  1. Long-Term Outcome Analysis of Peritoneal Dialysis and Hemodialysis in Patients With End-Stage Kidney Disease: A Real-World Data Chen YH, Chen YY, Fang YW, Liou HH, Wang JT, Tsai MH.Hemodial Int. 2025 May 27. doi: 10.1111/hdi.13267. Online ahead of print.PMID: 40421870

 

  1. Using Biologics to Reduce Long-Term Corticosteroid Use in Pyoderma Gangrenosum: Real-World Evidence From Two Centres. Cascio Ingurgio R, Alfano A, Gargiulo L, Ibba L, Narcisi A, Satgé F, Stark M, Costanzo A, Murrell DF.Australas J Dermatol. 2025 May 27. doi: 10.1111/ajd.14532. Online ahead of print.PMID: 40421919

 

  1. Nitazenes: review of comparative pharmacology and antagonist action. Stangeland M, Dale O, Skulberg AK.Clin Toxicol (Phila). 2025 May 27:1-14. doi: 10.1080/15563650.2025.2504133. Online ahead of print.PMID: 40422647 Review.

 

  1. The diagnostic status of chronic kidney disease in a real-world database in Japan: CHECK-CKD. Moriyama T, Kanafuri K, Kanno M, Niibe K, Nago S, Fukuoka I, Fukunaga Y, Doi I, Kawashima M.Clin Exp Nephrol. 2025 May 27. doi: 10.1007/s10157-025-02682-z. Online ahead of print.PMID: 40423762

 

  1. American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. Monagle P, Azzam M, Bercovitz R, Betensky M, Bhat R, Biss T, Branchford B, Brandão LR, Chan AKC, Faustino EVS, Jaffray J, Jones S, Kawtharany H, Kerlin BA, Kucine N, Kumar R, Male C, Pelland-Marcotte MC, Raffini L, Raulji C, Sartain SE, Takemoto CM, Tarango C, van Ommen CH, Velez MC, Vesely SK, Wiernikowski J, Williams S, Wilson HP, Woods G, Zia A, Mustafa RA.Blood Adv. 2025 May 27;9(10):2587-2636. doi: 10.1182/bloodadvances.2024015328.PMID: 40423983

 

  1. Non-Randomized Database Analyses to Complement Randomized Clinical Trials: Promising Approaches for Cardiovascular Medicine. Schneeweiss S, Krüger N. 2025 May 27;151(21):1495-1497. doi: 10.1161/CIRCULATIONAHA.125.073235. Epub 2025 May 27.PMID: 40424331 No abstract available.

 

  1. Clinical characteristics and response to growth hormone treatment in 27 children with heterozygous NPR2 variants: real-world data. Renes JS, Reedijk AMJ, Hokken-Koelega ACS, Hendriks YMC, Bakker B, Boot AM, van Setten PA, van der Kaay DCM, van Duyvenvoorde HA, Nievelstein RAJ, Losekoot M, de Bruin C.J Clin Endocrinol Metab. 2025 May 27:dgaf309. doi: 10.1210/clinem/dgaf309. Online ahead of print.PMID: 40424589

 

  1. Active Surveillance for Prostate Cancer in "Real-World" Setting: Exploring Racial Disparities. Finocchiaro A, Chiarelli G, Stephens A, Viganó S, Bertini A, Cusmano N, Guivatchian E, Dinesh A, Ficarra V, Sorce G, Briganti A, Montorsi F, Salonia A, Lughezzani G, Buffi N, Sood A, Rogers C, Abdollah F.J Racial Ethn Health Disparities. 2025 May 27. doi: 10.1007/s40615-025-02497-4. Online ahead of print.PMID: 40425976

 

  1. A probabilistic approach to visualize the effect of missing data on PCA in ancient human genomics. Zabel S, Breitling S, Posth C, Nieselt K.BMC Genomics. 2025 May 27;26(1):537. doi: 10.1186/s12864-025-11728-1.PMID: 40426041 Free PMC article.

 

  1. Real-world treatment patterns and outcomes for patients with non-metastatic non-small cell lung cancer: retrospective analyses in Canada, England, and Germany. Greystoke A, Daumont MJ, Rault C, Baltus H, Ding PQ, Emanuel G, Lucherini S, Vo L, Saglimbene VM, Ralphs E, Leal C, Schoemaker MJ, Katalinic A, Waldmann A, Cheung WY.BMC Pulm Med. 2025 May 27;25(1):265. doi: 10.1186/s12890-025-03715-9.PMID: 40426148 Free PMC article.

 

  1. Real-world evidence of biological treatments in rheumatoid arthritis and spondyloarthritis in Morocco: results of the RBSMR registry. El Ouardi N, Hmamouchi I, Abouqal R, Allali F, Bahiri R, El Bouchti I, Ghozlani I, Hassikou H, Ichchou L, Janani S, Harzy T, Niamane R, Bezza A, El Maghraoui A.BMC Rheumatol. 2025 May 27;9(1):62. doi: 10.1186/s41927-025-00510-1.PMID: 40426283 Free PMC article.

 

  1. Real-world effectiveness of MBA-VN vaccine against mpox, a test-negative case-control study. Escobar-Ziede P, Borras-Bermejo B, Pinós-Tella L, Vivet-Escalé M, Peñalver-Piñol A, Martinez J, Rodrigo-Pendás JÁ, García-Pérez J, Álvarez-López P, Nadal-Baron P, Antón A, Parés-Badell O. 2025 May 27;59:127295. doi: 10.1016/j.vaccine.2025.127295. Online ahead of print.PMID: 40435852

 

  1. Treatment Patterns and Long-Term Outcomes with Anti-VEGF Therapy for Retinal Vein Occlusion: An Analysis of the Vestrum Database. Ip M, Modi Y, Fekrat S, Gibson K, Boucher N, Arrisi P, Ishii F, Liu Y, Paris LP, Fenech M, Chi GC.Ophthalmol Retina. 2025 May 27:S2468-6530(25)00251-9. doi: 10.1016/j.oret.2025.05.025. Online ahead of print.PMID: 40441380

 

  1. Uncovering safety signals of duloxetine: Real-world evidence from the FAERS database. Liu D, Li N, Liu L, Qiu L, Zhou Z, Wu J.J Affect Disord. 2025 May 27:119517. doi: 10.1016/j.jad.2025.119517. Online ahead of print.PMID: 40441644

 

  1. Safety and efficacy of Deep TMS for adolescent depression based on large real-world data Roth Y, Tendler A, Pell GS, Tripp T, Yam P, DeKeyser D, Mekolle M, Tripp J, Dahl A, Muir OS, MacMillan CM, Rosi KR, Harvey SA, Poprawski T, Kinback KM, Adefolarin O, Rohr A, Blair ME, Ghelber D, Cho RY, Kelly HR, Garcia RC, Jha A, Bermudes RA, Hanlon CA.Psychiatry Res. 2025 May 27;350:116567. doi: 10.1016/j.psychres.2025.116567. Online ahead of print.PMID: 40449231

 

  1. A comprehensive overview of real-world evidence in medical device approvals in the United States. Goswami S, Masurkar PP, Kaul A.Expert Rev Med Devices. 2025 May 28:1-7. doi: 10.1080/17434440.2025.2512041. Online ahead of print.PMID: 40424463

 

  1. Real-world evaluation of automated insulin delivery therapy in type 1 diabetes: A multicentre study across regional and metropolitan Queensland, Australia. Konantambigi A, Wang W, Boggild D, Rana A, Syphers L, Presley C, Cummins C, Malabu U, Hawke K, Shenoy V, Puri G, Deshmukh H.Diabetes Obes Metab. 2025 May 28. doi: 10.1111/dom.16485. Online ahead of print.PMID: 40432403

 

  1. Clinical and economic outcomes of patients with cardiorenal and metabolic diseases: a real-world analysis in a single Italian Local Health Unit. Perrone V, Ancona DD, Gnesi M, Mongelli V, Migliaccio S, Renato Colanero F, Antonio Lenoci E, Bonfanti L, Leogrande M, Cappuccilli M, Procacci C, Degli Esposti L.Expert Rev Pharmacoecon Outcomes Res. 2025 May 28:1-11. doi: 10.1080/14737167.2025.2504944. Online ahead of print.PMID: 40433739

 

  1. Effect of Automated Insulin Delivery Using Hybrid Closed Loops in the Preconception, Peripartum and Postnatal Periods for Women With Type 1 Diabetes. Jones C, Morrison AE, Grudgings G, Evans S, Hamza M, Thayyil S, Dales J, Morgan H, Lawrence I, Maybury H, Choudhary P, Meek CL.J Diabetes Sci Technol. 2025 May 28:19322968251338863. doi: 10.1177/19322968251338863. Online ahead of print.PMID: 40433847 Free PMC article.

 

  1. SGLT2i Versus Metformin for Delirium Prevention in Type 2 Diabetes: A Real-World, Head- to-Head Comparative Study. Sun M, Wang X, Lu Z, Yang Y, Lv S, Miao M, Chen WM, Wu SY, Zhang J.Diabetes Care. 2025 May 28:dc250433. doi: 10.2337/dc25-0433. Online ahead of print.PMID: 40435363

 

  1. Improved outcomes over time in patients aged ≥60 years undergoing allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia in first complete remission: a large study by the EBMT acute leukemia working party. Moukalled N, Ferhat AT, Bazarbachi A, Blaise D, Broers AEC, Castilla-Llorente C, Wagner-Drouet E, Halkes C, Schroeder T, Passweg J, Yakoub-Agha I, Dreger P, Kröger N, Fanin R, Gabellier L, Blau IW, Brissot E, Nagler A, Giebel S, Mohty M, Ciceri F.Bone Marrow Transplant. 2025 May 28. doi: 10.1038/s41409-025-02630-1. Online ahead of print.PMID: 40437045

 

  1. Real-world data on trastuzumab emtansine (TDM1) efficacy and safety: Results of a single-centre retrospective study of HER2-positive metastatic breast cancer patients. Gupta A, Sansar B, Mishra BK, Khan A, Singh A, Upadhyay A, Chowdhury Z, Patne S, Tripathi M, Shukla S, Singh SN, Pujari L, Giridhar P, Kapoor AR, Suresh A, Dey S, Vinayak KR, Singh N, Kumar A, Pal A, Kapoor A.Sci Rep. 2025 May 28;15(1):18669. doi: 10.1038/s41598-025-97923-2.PMID: 40437155 Free PMC article.

 

  1. Application of Real-World Evidence to Support FDA Regulatory Decision Making. Khaowroongrueng V, Kim TE, Park SI, Shin KH.AAPS J. 2025 May 28;27(4):98. doi: 10.1208/s12248-025-01082-1.PMID: 40437343 Review.

 

  1. Costs analysis of radiotherapy for breast cancer in Indonesia: a comparison between reimbursement tariffs and actual costs. Suryanegara FDA, Iskandar D, Ekaputra E, Kuntjoro E, Setiawan D, Postma MJ, de Jong LA.BMC Health Serv Res. 2025 May 28;25(1):766. doi: 10.1186/s12913-025-12849-9.PMID: 40437477 Free PMC article.

 

  1. Lecanemab in clinical practice: real-world outcomes in early Alzheimer's disease. Bregman N, Nathan T, Shir D, Omer N, Levy MH, David AB, Aizenstien O, Lotan E, Alcalay Y, Awad AA, Gadoth A, Ash E, Shiner T.Alzheimers Res Ther. 2025 May 28;17(1):119. doi: 10.1186/s13195-025-01763-1.PMID: 40437535 Free PMC article.

 

  1. Risk of new-onset type 1 diabetes in individuals with celiac disease and thyroid disease-An observational study. Edelman SV, Agardh D, Cui N, Hao L, Wieloch M, Meneghini L.Diabetes Obes Metab. 2025 May 28. doi: 10.1111/dom.16454. Online ahead of print.PMID: 40437819

 

  1. Human Papillomavirus Infection is Associated with Increased Risk of Glaucoma: Real-World Evidence. Liao WC, Su YJ, Li YF, Lo SW, Lee CY, Chang HC, Gau SY. 2025 May 28:S0161-6420(25)00335-5. doi: 10.1016/j.ophtha.2025.05.019. Online ahead of print.PMID: 40447113

 

  1. Direct Oral Anticoagulants versus Standard Therapy in Upper Extremity Deep Vein Thrombosis: Real-World Evidence. Ruiz-Artacho P, Lecumberri R, Trujillo-Santos J, Beddar Chaib F, Moustafa F, Lorenzo A, Gómez-Cuervo C, Bosevski M, Monreal M; RIETE Investigators.Thromb Haemost. 2025 May 29. doi: 10.1055/a-2615-4513. Online ahead of print.PMID: 40389231

 

  1. Real-world outcomes of isatuximab with pomalidomide and dexamethasone for relapsed and/or refractory multiple myeloma. Chen W, You J, Lin L, Yan X, An G, Wang Y, Tian W, Ding K, Zhang X, Chen W, Wang Y, Fang B, Liu J, Xia W, Feng Z, Zhou L, Wang Z, Shen D, Liu G, Zhao W.Chin Med J (Engl). 2025 May 29. doi: 10.1097/CM9.0000000000003649. Online ahead of print.PMID: 40437669

 

  1. Colorectal Cancer in Pregnancy: Case Discussions and Real-World Data as well as literature review on current knowledge. Poulgrain S, Gibbons T, O'Leary C, Feng S, Jain V, O'Leary CG. 2025 May 29:oyaf097. doi: 10.1093/oncolo/oyaf097. Online ahead of print.PMID: 40437693 Free article.

 

  1. Successful or Uncomplicated Use of Drug-Coated Balloon Versus Drug-Eluting Stent Strategies for De Novo Culprit Lesions in Acute Coronary Syndromes: Insights from a Nationwide Registry in Japan. Takahashi T, Yamaji K, Kohsaka S, Ishii H, Mori Y, Kikuta Y, Wakatsuki T, Yamaguchi K, Nishioka D, Kusunose K, Amano T, Sata M, Kozuma K; J‐PCI Registry Investigators.J Am Heart Assoc. 2025 May 29:e038071. doi: 10.1161/JAHA.124.038071. Online ahead of print.PMID: 40439158 Free article.

 

  1. How well does loncastuximab tesirine work after chimeric antigen receptor T-cell treatment in diffuse large B-cell lymphoma? A plain language summary of a real-world evidence Epperla N, Lucero M, Bailey T, Mirams L, Cheung J, Amet M, Milligan G, Chen L.Future Oncol. 2025 May 29:1-10. doi: 10.1080/14796694.2025.2504802. Online ahead of print.PMID: 40439268

 

  1. Drug survival of IL-23 and IL-17 inhibitors versus other biologics for psoriasis: A British Association of Dermatologists Biologics and Immunomodulators Register cohort study. Motedayen Aval L, Yiu ZZN, Alabas OA, Griffiths CEM, Reynolds NJ, Hampton PJ, Smith CH, Warren RB; BADBIR Study Group.J Eur Acad Dermatol Venereol. 2025 May 29. doi: 10.1111/jdv.20739. Online ahead of print.PMID: 40439435

 

  1. Real-World Evidence on the Routine Use, Efficacy, and Safety of a Hyaluronic Acid-Based Dermal Filler in the Periorbital Region. Bhojani-Lynch T, Shah-Desai S, Bichet JC, Magalhães B, Poupard K.Aesthetic Plast Surg. 2025 May 29. doi: 10.1007/s00266-025-04809-9. Online ahead of print.PMID: 40442496

 

  1. Transforming Care in China by Using Public-Private Partnerships to Unlock the Power of Patient-Centered Real-World Data. Zhou M, Sun F, Xue F, Sjögren L, Xiao S, Zhang S, Chen P, Zhan S, Bedenkov A.Pharmaceut Med. 2025 May 29. doi: 10.1007/s40290-025-00571-0. Online ahead of print.PMID: 40442538

 

  1. Real-World Clinical Experience of Tralokinumab in a Tertiary Centre: An Alternative for Patients with Conjunctivitis on Dupilumab? Sebastian N, Chircop O, Clayton TH, Kreeshan FC, Hunter HJA, Warren RB.Dermatol Ther (Heidelb). 2025 May 29. doi: 10.1007/s13555-025-01446-7. Online ahead of print.PMID: 40442566

 

  1. Epidemiology, patient management, and survival outcomes in resected patients with non-metastatic non-small cell lung cancer: a nationwide real-world study. Renaud S, Casabianca P, Diez-Andreu P, Chartier M, Gaudin AF, Bugnard F, Bénard S, Cotté FE, Chouaid C.BMC Cancer. 2025 May 29;25(1):966. doi: 10.1186/s12885-025-14334-2.PMID: 40442643 Free PMC article.

 

  1. Cumulative risk of cosmetic worsening following ultra hypo-fractionated whole breast radiotherapy with simultaneous integrated boost: the largest real-world data. Wadasadawala DT, Syeda DN, Kenekar DS, Krishnamurthy DR, Sarin DR, Pathak DR, Rane P, Pawar MA, Upadhyay DP, Joshi DS, Parmar DV, Nair DN, Shejwal M, Chavan S.Int J Radiat Oncol Biol Phys. 2025 May 29:S0360-3016(25)00528-0. doi: 10.1016/j.ijrobp.2025.05.061. Online ahead of print.PMID: 40449565

 

  1. Depression and its association with mortality in idiopathic pulmonary fibrosis: A real-world data Takuma S, Hozumi H, Miyashita K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T.Respir Med. 2025 May 29:108185. doi: 10.1016/j.rmed.2025.108185. Online ahead of print.PMID: 40449566

 

  1. Characteristics, treatment and disease burden among stage 3-4 chronic kidney disease patients with and without type 2 diabetes in Finland during 2016-2022. Metsärinne K, Bodegård J, Toppila I, Uusi-Rauva K, Frederiksen LE, Brinkmann S.Nephrol Dial Transplant. 2025 May 30;40(6):1115-1123. doi: 10.1093/ndt/gfae242.PMID: 39510970

 

  1. Utility of plasma circulating DNA tumor fraction in bone-only metastatic breast cancer: a real-world outcomes study. Bader G, Quintanilha JCF, Veney D, Graf RP, Levy M, Pasquina LW, Stover DG.Breast Cancer Res Treat. 2025 May 30. doi: 10.1007/s10549-025-07740-4. Online ahead of print.PMID: 40445506

 

  1. Real-world effectiveness of cariprazine in major depressive disorder and bipolar I disorder in the United States. McIntyre RS, Parikh M, Ta J, Waraich S, Cohen-Stavi C, Marci C, Nabulsi N.J Med Econ. 2025 May 30:1-15. doi: 10.1080/13696998.2025.2513766. Online ahead of print.PMID: 40445745

 

  1. The Potential to Leverage Real-World Data for Pediatric Clinical Trials: A Proof-of-Concept Study. Declerck J, Lee J, Sen A, Palmeri A, Oostenbrink R, Giannuzzi V, Woodworth S, Malik S, Mahler F, Aurich B, Leary R, Kalra D, Straub V.J Med Internet Res. 2025 May 30;27:e72573. doi: 10.2196/72573.PMID: 40446289

 

  1. Development of a framework on the incorporation of real-world evidence (RWE) into cancer drug funding decisions in Canada: the Canadian Real-world Evidence for Value of Cancer Drugs (CanREValue) collaboration. Chan KK, Takhar P, Evans WK, Mercer RE, Denburg A, Beca J, Muñoz C, Gavura S, Cheung WY, Hoch J, Craig E, de Oliveira C, Geirnaert M, Trudeau M, Ahuja T, Peacock S, Dai WF, Isaranuwatchai W, Bombard Y, Chambers C, Earle CC, Alvi R, Pechlivanoglou P, Tadrous M.BMJ Open. 2025 May 30;15(5):e096286. doi: 10.1136/bmjopen-2024-096286.PMID: 40447425

 

  1. Behavior of test specificity under an imperfect gold standard: findings from a simulation study and analysis of real-world oncology data. Walker MS, Slipski L, Natanzon Y.BMC Med Res Methodol. 2025 May 30;25(1):151. doi: 10.1186/s12874-025-02603-4.PMID: 40448081

 

  1. Using computed tomography in fast stratification of intermediate risk pulmonary embolism and thrombus location: Realworld evidence Lovera M, Menjura S, Marín T.Med Clin (Barc). 2025 May 30;165(4):107025. doi: 10.1016/j.medcli.2025.107025. Online ahead of print.PMID: 40449404 English, Spanish. No abstract available.

 

  1. Clinical Management and Outcomes of Immune-Related Adverse Events During Treatment with Immune Checkpoint Inhibitor Therapies in Melanoma and Renal Cell Carcinoma: A UK Real-World Evidence Olsson-Brown A, Jain A, Frazer R, Farrugia D, Carser J, Houghton J, Lewis RD, D'Mello S, Emanuel G.Oncol Ther. 2025 May 31. doi: 10.1007/s40487-025-00349-z. Online ahead of print.PMID: 40448748

 

  1. Real-world characteristics and outcomes of patients with multiple myeloma treated with belantamab mafodotin: a German claims data study. Luna J, d'Estrube T, Jacobsen A, Lehne M, Wellmann-Pichler B, Mevius A, Dornig S.Ann Hematol. 2025 May 31. doi: 10.1007/s00277-025-06427-6. Online ahead of print.PMID: 40448822

 

  1. Bayesian Proactive Dynamic Borrowing Utilizing Propensity Score Overlap for a Hybrid Control Arm and the Impacts of Various Biases: A Simulation Study. Wang K, Cao H, Yao C.J Evid Based Med. 2025 Jun;18(2):e70022. doi: 10.1111/jebm.70022.PMID: 40195067

 

  1. A Comparative Analysis of Cardiovascular Events Associated With Acalabrutinib Versus Ibrutinib in Chronic Lymphocytic Leukemia: Insights From a Global Federated Network. Majrashi A, Gue YX, Shantsila A, Williams S, Smith CT, Lip GYH, Pettitt AR. Pharmacol Res Perspect. 2025 Jun;13(3):e70113. doi: 10.1002/prp2.70113.PMID: 40341807 Free PMC article.

 

  1. Efficacy and Treatment Outcomes of First-line Pazopanib Therapy in Advanced Renal Cell Carcinoma in Greece. Bournakis E, Xanthakis I, Vaslamatzis M, Makrantonakis P, Karanikiotis C, Athanasiadis I, Ardavanis A, Papakotoulas P, Samantas E, Papandreou C, Michailidou M, Katsaounis P, Christodoulou C. Anticancer Res. 2025 Jun;45(6):2527-2534. doi: 10.21873/anticanres.17624.PMID: 40425323

 

  1. Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System-Outcomes in Finland: A Nationwide Population-Based Study. Moisala M, Kalashnikov I, Haataja N, Leppä S, Pollari M. 2025 May 28;6(3):e70021. doi: 10.1002/jha2.70021. eCollection 2025 Jun.PMID: 40438704 Free PMC article.

 

  1. Cost-effectiveness of pembrolizumab for the first-line treatment of recurrent or metastatic head and neck squamous cell carcinoma in Colombia. Urrego-Reyes J, Marrugo Arnedo C, Jaramillo H, Realpe OE, Rojas MM, Patel A, Black C, Borse R.J Med Econ. 2025 Dec;28(1):823-834. doi: 10.1080/13696998.2025.2510807. Epub 2025 May 31.PMID: 40417835 Free article.Clinical Trial.